BCAL Diagnostics Limited (ASX:BDX)
Australia · Delayed Price · Currency is AUD 0.1150
0.00 (0.00%)
Feb 4, 2026, 3:46 PM AEST
BCAL Diagnostics Market Cap
BCAL Diagnostics has a market cap or net worth of 42.33 million as of February 4, 2026. Its market cap has increased by 24.23% in one year.
Market Cap
42.33M
Enterprise Value
40.18M
Revenue
2.65M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.12
Market Cap Chart
Since July 21, 2021, BCAL Diagnostics's market cap has decreased from 51.72M to 42.33M, a decrease of -18.16%. That is a compound annual growth rate of -4.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 4, 2026 | 42.33M | 9.52% |
| Dec 31, 2025 | 38.65M | 8.87% |
| Dec 31, 2024 | 35.50M | 42.50% |
| Dec 29, 2023 | 24.91M | 96.37% |
| Dec 29, 2022 | 12.69M | -50.95% |
| Dec 29, 2021 | 25.87M | -49.99% |
| Jul 21, 2021 | 51.72M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Integral Diagnostics | 976.51M |
| Healius | 653.52M |
| Australian Clinical Labs | 521.15M |
| Monash IVF Group | 274.69M |
| Microba Life Sciences | 54.20M |
| Cryosite | 51.74M |
| INOVIQ | 49.98M |
| Rhythm Biosciences | 47.42M |